Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mallmann

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|January 1, 1996
Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assayC M Kurbacher, I A Cree, U Brenne, et al.
Journal of Andrology|July 2, 2011
Vitrification of human ICSI/IVF spermatozoa without cryoprotectants: new capillary technologyV Isachenko, R Maettner, A M Petrunkina, et al.
Clinical Laboratory|October 28, 2011
Cryoprotectant-free vitrification of human spermatozoa in large (up to 0.5 mL) volume: a novel technologyV Isachenko, R Maettner, A M Petrunkina, et al.
Gynecologic Oncology|December 7, 2002
Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: a phase I studyD T Rein, C M Kurbacher, M Breidenbach, et al.
Cancer Letters|February 3, 2000
Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomasT Schöndorf, A Scharl, C M Kurbacher, et al.
Journal of Reproductive Immunology|October 1, 1994
Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortions. German RSA/IVIG Study GroupG Mueller-Eckhardt, P Mallmann, J Neppert, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1996
[Pain therapy with rhenium-186 HEDP in multiple bone metastases]H Palmedo, H Bender, A Schomburg, et al.
European Journal of Cancer Care|January 29, 2010
Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patientsM Hoopmann, K Sachse, M M Valter, et al.
Anticancer Research|May 1, 2001
Lack of correlation between P53 expression, BCL-2 expression, apoptosis and ex vivo chemosensitivity in advanced human breast cancerD T Rein, T Schöndorf, M Breidenbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trialC M Kurbacher, H W Bruckner, I A Cree, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|January 1, 1996
Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assayC M Kurbacher, I A Cree, U Brenne, et al.
Journal of Andrology|July 2, 2011
Vitrification of human ICSI/IVF spermatozoa without cryoprotectants: new capillary technologyV Isachenko, R Maettner, A M Petrunkina, et al.
Clinical Laboratory|October 28, 2011
Cryoprotectant-free vitrification of human spermatozoa in large (up to 0.5 mL) volume: a novel technologyV Isachenko, R Maettner, A M Petrunkina, et al.
Gynecologic Oncology|December 7, 2002
Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: a phase I studyD T Rein, C M Kurbacher, M Breidenbach, et al.
Cancer Letters|February 3, 2000
Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomasT Schöndorf, A Scharl, C M Kurbacher, et al.
Journal of Reproductive Immunology|October 1, 1994
Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortions. German RSA/IVIG Study GroupG Mueller-Eckhardt, P Mallmann, J Neppert, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1996
[Pain therapy with rhenium-186 HEDP in multiple bone metastases]H Palmedo, H Bender, A Schomburg, et al.
European Journal of Cancer Care|January 29, 2010
Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patientsM Hoopmann, K Sachse, M M Valter, et al.
Anticancer Research|May 1, 2001
Lack of correlation between P53 expression, BCL-2 expression, apoptosis and ex vivo chemosensitivity in advanced human breast cancerD T Rein, T Schöndorf, M Breidenbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trialC M Kurbacher, H W Bruckner, I A Cree, et al.
Pageof 12